Pharmacogenomic Testing to Guide Personalized Cancer Medicine Decisions in ... [READ MORE]

- Frontiers in Oncology

Combination of solid and liquid biopsy genomic profiling for tumor heterogeneity characterization

- ESMO

Tumor-biopsy analyses based on combined mTOR-pathway biomarkers ... [READ MORE]

- Oncotarget

Genomic Profiling for Patients with Solid Tumors: A Single-Institution Experience ... [READ MORE]

- Annals of Clinical Oncology

The clinical impact of using complex molecular profiling strategies in routine oncology practice ... [READ MORE]

- Oncotarget

Multi-factor Data Normalization enables the detection of LOH in amplicon sequencing data predictions ... [READ MORE]

- JOBIM 2019

Mutation profiling of both cfDNAs and CTCs in gynecological cancer patients ...

[READ MORE]

- www.biorxiv.org

EML4-ALK translocation identification in RNA exosomal cargo (ExoALK) in NSCLC patients: a novel role for liquid biopsy

- Translational Cancer Research

Circulating tumor DNA in early response assessment and monitoring... [READ MORE]

- Oncotarget

A Case Report Demonstrating the Potential Clinical Benefit of Exhaustive Molecular Profiling in an Aggressive Muscle-Invasive ... [READ MORE]

- Oncotarget

Combining analysis of solid and liquid biopsy: insights into tumor heterogeneity ... [READ MORE]

- Oncotarget

The combined analysis of solid and liquid biopsies provides additional clinical information ... [READ MORE]

- J. of Cancer Metastasis and Treatment